Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Filippo Pierangeli"'
Autor:
Veronica Gabusi, Massimo Campieri, Rosy Tambasco, Filippo Pierangeli, Gilberto Poggioli, Paolo Gionchetti, G. Di Febo, Carlo Calabrese, Fernando Rizzello, Giuseppina Liguori
Publikováno v:
Alimentary Pharmacology & Therapeutics. 27:759-764
Summary Background Chronic refractory pouchitis is a long-term complication after ileal pouch-anal anastomosis and it may be associated with ileal inflammation. Aim To determine the efficacy of infliximab in treatment of chronic refractory pouchitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c70889c19cf83f85c77fe26da9c16668
https://doi.org/10.1111/j.1365-2036.2008.03656.x
https://doi.org/10.1111/j.1365-2036.2008.03656.x
Autor:
Gianluca M. Sampietro, Gaurav A. Upadhyay, Victor W. Fazio, Filippo Pierangeli, Angelo Maria Taschieri, Marilena Fazi, Yuji Funayama, Francesco Tonelli, Fabrizio Michelassi, Gilberto Poggioli, Iwao Sasaki, Roger D. Hurst
Publikováno v:
Diseases of the Colon & Rectum. 50:277-284
The side-to-side strictureplasty is a bowel-sparing alternative to resection in the treatment of stricturing Crohn’s disease. This study was initiated to review the adoption of the side-to-side strictureplasty as a new surgical technique and the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7e6c169fa8ba705e1e107c225230307
https://doi.org/10.1007/s10350-006-0804-y
https://doi.org/10.1007/s10350-006-0804-y
Autor:
Silvio Laureti, Rosy Tambasco, Carlo Calabrese, Filippo Pierangeli, Massimo Campieri, Gilberto Poggioli, Paolo Gionchetti, C. Morselli, Fernando Rizzello
Publikováno v:
Alimentary Pharmacology & Therapeutics. 25:1231-1236
SUMMARY Background Pouchitis is the major long-term complication after ileal-pouch nal anastomosis for ulcerative colitis. Ten to 15% of patients develop a chronic pouchitis, either treatment responsive or treatment refractory. Aim To evaluate the ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cec6b305cfd7f8dea5d744aca09d4fba
https://doi.org/10.1111/j.1365-2036.2007.03306.x
https://doi.org/10.1111/j.1365-2036.2007.03306.x
Autor:
Federica Ugolini, Silvio Laureti, Filippo Pierangeli, Fernando Rizzello, Massimo Campieri, Gilberto Poggioli, Paolo Gionchetti
Publikováno v:
Diseases of the Colon & Rectum. 48:768-774
Perianal disease is a serious complication of Crohn’s disease and its surgical management is still controversial. It has been suggested that the local injection of infliximab has resulted in some potential benefit. This pilot study analyzed the fea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d20dbd19a46d577ce3bfab98a0896fb4
https://doi.org/10.1007/s10350-004-0832-4
https://doi.org/10.1007/s10350-004-0832-4
Publikováno v:
Diseases of the Colon & Rectum. 46:127-130
Conservative surgery has become the treatment of choice for diffuse jejunoileal Crohn's Disease. Previous research described a conservative approach both for multiple strictures located in close proximity to each other and for long stenoses. The side
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f66eb59647250978eb4fa15b6abfcb9
https://doi.org/10.1007/s10350-004-6508-2
https://doi.org/10.1007/s10350-004-6508-2
Publikováno v:
Alimentary Pharmacology & Therapeutics. 16:59-64
The large majority of patients affected by Crohn's disease require surgery during their clinical history. Radical resection originally advocated for Crohn's disease does not decrease the recurrence rate, and repeated resections predispose patients to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08a1f52d40d42ca7473d8cd50dffa05b
https://doi.org/10.1046/j.1365-2036.16.s4.9.x
https://doi.org/10.1046/j.1365-2036.16.s4.9.x
Autor:
Alighieri Mazziotti, Filippo Pierangeli, Massimo Del Gaudio, Antonino Cavallari, Giorgio Ercolani, Gian Luca Grazi, Matteo Cescon
Publikováno v:
Annals of Surgery. 234:71-78
During the past two decades, hepatocellular carcinoma (HCC) has been one of the most intriguing diseases to treat. The problem of treatment remains open, especially for patients with underlying cirrhosis of the liver, which substantially reduces the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f997cd68f3a0cec190071dca6cb803b
https://doi.org/10.1097/00000658-200107000-00011
https://doi.org/10.1097/00000658-200107000-00011
Autor:
Matteo Cescon, Matteo Ravaioli, Alighieri Mazziotti, Filippo Pierangeli, Giorgio Ercolani, Antonietta D'Errico, Gian Luca Grazi, Lorenza Ridolfi, Antonino Cavallari
Publikováno v:
American Journal of Transplantation. 1:61-68
The upper age limit for organ donation for liver transplantation has increased over the past few years. A retrospective case control study was carried out to evaluate the outcome of 36 liver transplants (group A) performed with grafts procured from d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20a2409dde5a82f3d4fe7d9f02921d67
https://doi.org/10.1034/j.1600-6143.2001.010112.x
https://doi.org/10.1034/j.1600-6143.2001.010112.x
Autor:
Massimo Campieri, Lorenzo Gentilini, Fernando Rizzello, Federica Ugolini, Gilberto Poggioli, Paolo Gionchetti, Maurizio Coscia, Silvio Laureti, Piero Bazzi, Filippo Pierangeli
Publikováno v:
Therapeutics and Clinical Risk Management
The recent introduction of infliximab, a chimeric monoclonal antibody against tumor necrosis factor-alpha, has greatly modified the treatment of Crohn's disease (CD). Data from the literature show encouraging results after intravenous infusion both f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17bff028cb0361c74d3c771491a9807a
http://hdl.handle.net/11585/73951
http://hdl.handle.net/11585/73951
